Lumida
/CVRX
⌘K
CVRx Inc

CVRx Inc

CVRX
$4.91USD-8.91%-0.48 today

MARKET CAP

130.3M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$4
$11

AI Summary

Stalk
StalkMedium

Yesterday’s bearish medium-term stance was invalidated by late-June’s F candle and Bullish Pivot Point closing above the 9/21 EMAs, signaling structural repair. CVRX now sits in an early Stage 1 consolidation below the 50 DMA with medium-term bias turned Bullish. Short-term timing is Neutral; execution should be deferred by stalking pullbacks into the 9/21 EMA support or lower consolidation boundary. A decisive close below the 9/21 EMA region would invalidate this bullish posture.

  • Q1 2026 revenue $14.8M (+20% YoY); U.S. heart failure sales $13.7M (+22%).
  • Active implanting centers grew to 257 after expanding sales force.
  • Q1 net loss $13.1M ($0.50/sh) underscores weak profitability.
Full analysis →
Insider Trades15 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 2, 2026SellCVRXPhilip B. AdamsonChief Medical Officer1,262$7.90$130.3M-56.55%+12.35%$10.0K-1.01%Stalk
Mar 2, 2026SellCVRXPaul VerrastroCHIEF MKTG & STRAT OFFICER1,284$7.90$130.3M-56.55%+12.35%$10.1K-1.00%Stalk
Mar 2, 2026SellCVRXJared OasheimCHIEF FINANCIAL OFFICER1,744$7.90$130.3M-56.55%+12.35%$13.8K-0.92%Stalk
Mar 2, 2026SellCVRXRobert Allen JohnChief Revenue Officer3,964$7.90$130.3M-56.55%+12.35%$31.3K-2.79%Stalk
Mar 2, 2026SellCVRXKevin HykesPRES & CEO7,763$7.90$130.3M-56.55%+12.35%$61.3K-1.46%Stalk
May 12, 2025BuyCVRXKevin HykesPRES & CEO5,000$4.84$130.3M-56.55%+12.35%$24.2K+3.91%Stalk
Nov 19, 2024BuyCVRXPaul VerrastroCHIEF MKTG & STRAT OFFICER4,970$6.49$130.3M-56.55%+12.35%$32.3K+0.04%Stalk
Aug 5, 2024BuyCVRXKevin HykesPRES & CEO30,000$8.36$130.3M-56.55%+12.35%$250.8KStalk
Mar 25, 2024BuyCVRXCraig E. PalmerSVP, U.S. SALES934$0.24$130.3M-56.55%+12.35%$221.358+45.63%Stalk
Feb 23, 2024SellCVRXPaul VerrastroCHIEF MKTG & STRAT OFFICER1,650$22.21$130.3M-56.55%+12.35%$36.6K-67.21%Stalk
Feb 20, 2024BuyCVRXPaul VerrastroCHIEF MKTG & STRAT OFFICER7,545$10.80$130.3M-56.55%+12.35%$81.5K+3.04%Stalk
Jan 29, 2024BuyCVRXNadim YaredCHIEF EXECUTIVE OFFICER6,000$0.24$130.3M-56.55%+12.35%$1.4K+8.15%Stalk
Oct 16, 2023BuyCVRXLiz GalleVP OF GLOBAL CLINICAL RESEARCH778$0.24$130.3M-56.55%+12.35%$184.386Stalk
Sep 18, 2023BuyCVRXJared OasheimCHIEF FINANCIAL OFFICER5,862$3.62$130.3M-56.55%+12.35%$21.2K+18.65%Stalk
Aug 3, 2023SellCVRXPaul VerrastroCHIEF MKTG & STRAT OFFICER628$18.55$130.3M-56.55%+12.35%$11.7K-100.00%Stalk